Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment.
Chodorge M, Celeste AJ, Grimsby J, Konkar A, Davidsson P, Fairman D, Jenkinson L, Naylor J, White N, Seaman JC, Dickson K, Kemp B, Spooner J, Rossy E, Hornigold DC, Trevaskis JL, Bond NJ, London TB, Buchanan A, Vaughan T, Rondinone CM, Osbourn JK.
Chodorge M, et al. Among authors: london tb.
Sci Rep. 2018 Dec 3;8(1):17545. doi: 10.1038/s41598-018-35869-4.
Sci Rep. 2018.
PMID: 30510163
Free PMC article.